WO2016137266A3 - Pharmaceutical composition containing eperisone and pelubiprofen - Google Patents
Pharmaceutical composition containing eperisone and pelubiprofen Download PDFInfo
- Publication number
- WO2016137266A3 WO2016137266A3 PCT/KR2016/001911 KR2016001911W WO2016137266A3 WO 2016137266 A3 WO2016137266 A3 WO 2016137266A3 KR 2016001911 W KR2016001911 W KR 2016001911W WO 2016137266 A3 WO2016137266 A3 WO 2016137266A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pelubiprofen
- pharmaceutical composition
- composition containing
- eperisone
- containing eperisone
- Prior art date
Links
- SQUNAWUMZGQQJD-UHFFFAOYSA-N 1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one Chemical compound C1=CC(CC)=CC=C1C(=O)C(C)CN1CCCCC1 SQUNAWUMZGQQJD-UHFFFAOYSA-N 0.000 title abstract 2
- AUZUGWXLBGZUPP-GXDHUFHOSA-N 2-[4-[(e)-(2-oxocyclohexylidene)methyl]phenyl]propanoic acid Chemical compound C1=CC(C(C(O)=O)C)=CC=C1\C=C/1C(=O)CCCC\1 AUZUGWXLBGZUPP-GXDHUFHOSA-N 0.000 title abstract 2
- 229960002565 eperisone Drugs 0.000 title abstract 2
- 229950010552 pelubiprofen Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229920003176 water-insoluble polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Disclosed is a pharmaceutical composition containing pelubiprofen, eperisone, and a water insoluble polymer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150028626A KR20160105662A (en) | 2015-02-27 | 2015-02-27 | Pharmaceutical composition comprising eperison and pelubiprofen |
KR10-2015-0028626 | 2015-02-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2016137266A2 WO2016137266A2 (en) | 2016-09-01 |
WO2016137266A3 true WO2016137266A3 (en) | 2016-10-20 |
Family
ID=56789724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2016/001911 WO2016137266A2 (en) | 2015-02-27 | 2016-02-26 | Pharmaceutical composition containing eperisone and pelubiprofen |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20160105662A (en) |
WO (1) | WO2016137266A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101856911B1 (en) * | 2017-12-13 | 2018-05-10 | 동국대학교 산학협력단 | Pharmaceutical composition of sustained-release solid dispersion of pelubiprofen and method for producing the same |
KR102462607B1 (en) * | 2020-11-11 | 2022-11-03 | 대원제약주식회사 | Pharmaceutical composition with improved stability comprising novel salt of pelubiprofen as an active ingredient |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050114921A (en) * | 2004-06-02 | 2005-12-07 | 씨제이 주식회사 | Controlled release pharmaceutical compositions |
KR20080059409A (en) * | 2005-09-30 | 2008-06-27 | 임팩스 라보라토리즈, 인코포레이티드 | Pharmaceutical dosage forms having immediate release and/or controlled release properties |
KR20090114323A (en) * | 2008-04-29 | 2009-11-03 | 한올제약주식회사 | Pharmaceutical Formulation |
KR20100053424A (en) * | 2009-07-06 | 2010-05-20 | 대원제약주식회사 | Pharmaceutical formulation having improved dissolution rate and stability for oral administration containing pelubiprofen |
KR20140118412A (en) * | 2013-03-29 | 2014-10-08 | 초당약품공업 주식회사 | Slow release pharmaceutical composition having Eperisone as active ingredient |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5007790A (en) | 1989-04-11 | 1991-04-16 | Depomed Systems, Inc. | Sustained-release oral drug dosage form |
KR20080039400A (en) | 2005-07-07 | 2008-05-07 | 파남 컴퍼니스 인크. | Sustained release pharmaceutical compositions for highly water soluble drugs |
-
2015
- 2015-02-27 KR KR1020150028626A patent/KR20160105662A/en not_active Application Discontinuation
-
2016
- 2016-02-26 WO PCT/KR2016/001911 patent/WO2016137266A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050114921A (en) * | 2004-06-02 | 2005-12-07 | 씨제이 주식회사 | Controlled release pharmaceutical compositions |
KR20080059409A (en) * | 2005-09-30 | 2008-06-27 | 임팩스 라보라토리즈, 인코포레이티드 | Pharmaceutical dosage forms having immediate release and/or controlled release properties |
KR20090114323A (en) * | 2008-04-29 | 2009-11-03 | 한올제약주식회사 | Pharmaceutical Formulation |
KR20100053424A (en) * | 2009-07-06 | 2010-05-20 | 대원제약주식회사 | Pharmaceutical formulation having improved dissolution rate and stability for oral administration containing pelubiprofen |
KR20140118412A (en) * | 2013-03-29 | 2014-10-08 | 초당약품공업 주식회사 | Slow release pharmaceutical composition having Eperisone as active ingredient |
Also Published As
Publication number | Publication date |
---|---|
KR20160105662A (en) | 2016-09-07 |
WO2016137266A2 (en) | 2016-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3191530A4 (en) | Solution polymers including one or more 1,1-disubstituted alkene compounds, solution polymerization methods, and polymer compositions | |
EP3119424A4 (en) | Immunogenic glycopeptides, composition comprising the glycopeptides and use thereof | |
EP3275916A4 (en) | Polymer, oxidized polymer, polymer composition, gel-type polymer composition, and use thereof | |
EP3190100A4 (en) | Polymerizable compound, polymer, polymerizable composition, and film | |
EP3241852A4 (en) | Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof | |
WO2015168225A3 (en) | Alkoxy polycarbonates, bisphenol monomers and methods of making and using the same | |
SA518391465B1 (en) | Synthetic Polymer Based Fluid Loss Pill | |
IL252897A0 (en) | Indenyl compounds, pharmaceutical compositions, and medical uses thereof | |
EP3409718A4 (en) | Modifier and modified conjugated diene-based polymer containing functional group derived therefrom | |
EP3449924A4 (en) | Composition, crocins active site, and uses thereof | |
EP3353228A4 (en) | Polymers containing cyclobutanediol and 2,2-bis(hydroxymethyl)alkylcarboxylic acid | |
EP3325527A4 (en) | Antiseptic polymer and synthesis thereof | |
EP3559120A4 (en) | Aqueous polymer composition | |
EP3101037A4 (en) | Modified conjugated diene-based polymer, preparation method therefor, and rubber composition containing same | |
EP3478663A4 (en) | Lactam-functionalized polymer, compositions and applications thereof | |
EP3434745A4 (en) | Polymer composition | |
EP3559128A4 (en) | Aqueous polymer composition | |
EP3214110A4 (en) | Polymerization composition, polymer using polymerization composition, and polymer electrolyte membrane using polymer | |
EP3688112A4 (en) | One-pack polymer modifiers | |
MX2017000497A (en) | Tablet dishwashing detergent and methods for making and using the same. | |
EP3688092A4 (en) | Aqueous polymer composition | |
WO2016063289A3 (en) | Pharmaceutical tablet compositions comprising rifaximin | |
EP3150611A4 (en) | Cyclic carbonate monomer containing double-sulfur five-membered ring functional group, and preparation method thereof | |
WO2016137266A3 (en) | Pharmaceutical composition containing eperisone and pelubiprofen | |
EP3585737A4 (en) | Polymer flooding produced water treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16755916 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16755916 Country of ref document: EP Kind code of ref document: A2 |